Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial

Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial

Abstract Objectives The objective of this trial is to assess whether early antiviral therapy in outpatients with COVID-19 with either favipiravir plus lopinavir/ritonavir, lopinavir/ritonavir alone, or favipiravir alone, is associated with a decrease in viral load of SARS-CoV-2 compared with placebo...

Full description

Bibliographic Details
Main Authors: Li-An K. Brown, Nick Freemantle, Judy Breuer, Hakim-Moulay Dehbi, Kashfia Chowdhury, Gemma Jones, Felicia Ikeji, Amalia Ndoutoumou, Krishneya Santhirakumar, Nicky Longley, Anna M. Checkley, Joseph F. Standing, David M. Lowe
Format: Article
Language:English
Published: BMC 2021-03-01
Series:Trials
Subjects:
COVID-19
randomised controlled trial
protocol
factorial design
placebo-controlled trial
favipiravir
Online Access:https://doi.org/10.1186/s13063-021-05139-2

Internet

https://doi.org/10.1186/s13063-021-05139-2

Similar Items